Stephen M. Lynch

844 total citations
29 papers, 563 citations indexed

About

Stephen M. Lynch is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stephen M. Lynch has authored 29 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 8 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stephen M. Lynch's work include Opioid Use Disorder Treatment (6 papers), Cyclopropane Reaction Mechanisms (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Stephen M. Lynch is often cited by papers focused on Opioid Use Disorder Treatment (6 papers), Cyclopropane Reaction Mechanisms (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Stephen M. Lynch collaborates with scholars based in United States, United Kingdom and Switzerland. Stephen M. Lynch's co-authors include Albert Padwa, Scott K. Bur, Michael A. Brodney, John D. Ginn, Peter Wipf, Christopher E. Goldring, Parveen Sharma, Hongjun Zhang, José M. Mejía‐Oneto and Anne Birmingham and has published in prestigious journals such as Biochemical Journal, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Stephen M. Lynch

28 papers receiving 553 citations

Peers

Stephen M. Lynch
Fabien Lecomte United Kingdom
Daniel Kuzmich United States
Andrew Germain United States
Larry A. Spangle United States
David C. Moebius United States
Steven D. Knight United States
Fabien Lecomte United Kingdom
Stephen M. Lynch
Citations per year, relative to Stephen M. Lynch Stephen M. Lynch (= 1×) peers Fabien Lecomte

Countries citing papers authored by Stephen M. Lynch

Since Specialization
Citations

This map shows the geographic impact of Stephen M. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Lynch more than expected).

Fields of papers citing papers by Stephen M. Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen M. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Lynch. The network helps show where Stephen M. Lynch may publish in the future.

Co-authorship network of co-authors of Stephen M. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Lynch. A scholar is included among the top collaborators of Stephen M. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen M. Lynch. Stephen M. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jenkins, Rosalind E., et al.. (2021). Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification. Archives of Toxicology. 95(7). 2413–2430. 2 indexed citations
2.
Lynch, Stephen M., et al.. (2021). P263 Irinotecan induces a rapid increase in enteroid permeability. A177.2–A178.
3.
Cox, Christopher R., Stephen M. Lynch, Christopher E. Goldring, & Parveen Sharma. (2020). Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury. Frontiers in Medical Technology. 2. 611913–611913. 38 indexed citations
4.
Pergolizzi, Joseph V., et al.. (2015). (448) Safety and effectiveness of once-daily hydrocodone in patients switching from an oral morphine regimen. Journal of Pain. 16(4). S88–S88. 1 indexed citations
5.
Lynch, Stephen M., et al.. (2014). Dibenzazepines and dibenzoxazepines as sodium channel blockers. Bioorganic & Medicinal Chemistry Letters. 25(1). 43–47. 13 indexed citations
6.
Lynch, Stephen M., et al.. (2014). N-Aryl azacycles as novel sodium channel blockers. Bioorganic & Medicinal Chemistry Letters. 25(1). 48–52. 9 indexed citations
7.
Jaime‐Figueroa, Saul, Javier de Vicente, Johannes C. Hermann, et al.. (2013). Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2522–2526. 31 indexed citations
8.
Lynch, Stephen M., Johannes C. Hermann, Saul Jaime‐Figueroa, et al.. (2013). Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome. Bioorganic & Medicinal Chemistry Letters. 23(9). 2793–2800. 28 indexed citations
9.
Wen, Warren, et al.. (2011). Time dependency of adverse events with Butrans™ (buprenorphine) transdermal system. Journal of Pain. 12(4). P62–P62. 1 indexed citations
10.
Wen, Warren, et al.. (2011). The adverse event profile of Butrans™ (buprenorphine) transdermal system in patients ≥ 65 and < 65 years of age. Journal of Pain. 12(4). P63–P63. 2 indexed citations
11.
Lucas, Matthew C., Robert J. Weikert, David S. Carter, et al.. (2010). Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain. Bioorganic & Medicinal Chemistry Letters. 20(18). 5559–5566. 15 indexed citations
12.
Wipf, Peter, et al.. (2005). Synthesis and biological activity of prodrug inhibitors of the thioredoxin–thioredoxin reductase system. Organic & Biomolecular Chemistry. 3(21). 3880–3880. 14 indexed citations
13.
Padwa, Albert, Stephen M. Lynch, José M. Mejía‐Oneto, & Hongjun Zhang. (2005). Cycloaddition Chemistry of 2-Vinyl-Substituted Indoles and Related Heteroaromatic Systems. The Journal of Organic Chemistry. 70(6). 2206–2218. 45 indexed citations
14.
Wipf, Peter, Stephen M. Lynch, Anne Birmingham, et al.. (2004). Natural product based inhibitors of the thioredoxin–thioredoxin reductase system. Organic & Biomolecular Chemistry. 2(11). 1651–1658. 52 indexed citations
15.
Padwa, Albert, Michael A. Brodney, Stephen M. Lynch, et al.. (2004). A New Strategy toward Indole Alkaloids Involving an Intramolecular Cycloaddition/Rearrangement Cascade. The Journal of Organic Chemistry. 69(11). 3735–3745. 32 indexed citations
16.
Padwa, Albert, Michael A. Brodney, Stephen M. Lynch, Sivaraman Dandapani, & Dennis P. Curran. (2002). Preparation and Diels-Alder reaction of a 2-amido substituted furan: Tert-butyl 3a-methyl-5-oxo-2,3,3a, 4,5,6-hexahydroindole-1-carboxylate: (1H-lndole-1-carboxylic acid, 2,3,3a, 4,5,6-hexahydro-3a-methyl-5-oxo-, 1,1-dimethylethyl ester). Organic Syntheses. 78. 202–211. 11 indexed citations
17.
Lynch, Stephen M., Scott K. Bur, & Albert Padwa. (2002). Intramolecular Amidofuran Cycloadditions across an Indole π-Bond:  An Efficient Approach to theAspidospermaandStrychnosABCECore. Organic Letters. 4(26). 4643–4645. 33 indexed citations
18.
Padwa, Albert, et al.. (2002). A New Construct of the cis-3a-Aryloctahydroindole Skeleton via the [4+2] Cycloaddition of Furanyl Carbamates. Heterocycles. 58(1). 227–227. 3 indexed citations
19.
Bur, Scott K., Stephen M. Lynch, & Albert Padwa. (2002). Influence of Ground-State Conformations on the Intramolecular Amidofuran Diels−Alder Reaction. Organic Letters. 4(4). 473–476. 26 indexed citations
20.
Padwa, Albert, et al.. (2001). Application of the tandem thionium/N-acyliminium ion cascade toward heterocyclic synthesis. Journal of the Brazilian Chemical Society. 12(5). 571–585. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026